StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3047% below fair value
$1.32−0.04 (-2.94%)

Close on Nov 16, 2026Market cap $6.07MP/E –Yield –

Biomerica EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Biomerica's EV/EBITDA was 15.1× on Dec 31, 2013, against 5.2× a year earlier. Over the last 2 years it ranged from 4.7× to 20.0×, with a median of 6.9×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2013Dec 31, 201315.1×+9.9
2012Dec 31, 20125.2×−12.3
2011Dec 30, 201117.5×–

More Biomerica figures

See a number that looks wrong?